Mirxes Holding Company Limited, a micro ribonucleic acid technology company, provides diagnostic solutions for the screening of cancer, cardiovascular, metabolic, and infectious diseases accessible across Singapore and China. The company offers GASTROClear, a blood-based miRNA detection panel consisting of 12 miRNA biomarkers for gastric cancer screening; LUNGClear, a lung cancer screening product candidate; and Fortitude COVID-19 RT-qPCR test kits. It also researches, develops, and manufactures biotechnology, life, and medical science related products. The company was founded in 2014 and is headquartered in Singapore.
तुलना करने के लिए मीट्रिक्स | 2629 | क्षेत्र सेक्टर - संबंधित क्षेत्र की कंपनियों के व्यापक समूह से मेट्रिक्स का औसत हेल्थकेयर | संबंध संबंध2629पीअर्सक्षेत्र | |
|---|---|---|---|---|
पी/ई अनुपात | −11.6x | −3.0x | −0.5x | |
PEG अनुपात | - | 0.00 | 0.00 | |
क़ीमत/बुक | 8.5x | 4.7x | 2.6x | |
क़ीमत / एलटीएम बिक्री | 41.9x | 25.0x | 3.3x | |
अपसाइड (विश्लेषक लक्ष्य) | 327.6% | 325.6% | 46.0% | |
उचित मूल्य अपसाइड | अनलॉक करें | 15.8% | 5.4% | अनलॉक करें |